Humana

eShare Welcomes Tom Porter as New Principal Technical Advisor

Retrieved on: 
Tuesday, April 9, 2024
SCG, Pleasure, Organization, Growth, Humana, Fashion design

WALTHAM, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- eShare is excited to announce the appointment of Tom Porter as the new Principal Technical Advisor, effective immediately.

Key Points: 
  • WALTHAM, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- eShare is excited to announce the appointment of Tom Porter as the new Principal Technical Advisor, effective immediately.
  • Tom brings over three decades of IT and communication systems expertise to eShare, significantly enriching technical leadership teams.
  • Before joining eShare, Tom distinguished himself at Humana, where he served as Lead Unified Communications Engineer.
  • Tom expressed his enthusiasm by stating, "Joining eShare represents a significant milestone in my career.

CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against agilon health, inc.

Retrieved on: 
Saturday, April 6, 2024
Risk, District court, UnitedHealth Group, Defendant, Lead, LLP, COPY, News, IPO, Humana, Hope, Medicare, Court, Register

RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).

Key Points: 
  • RADNOR, Pa., April 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ( NYSE: AGL ) (“agilon” or the “Company”).
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

Humana Inc. to Release First Quarter 2024 Results on April 24, 2024

Retrieved on: 
Monday, April 8, 2024
Professional Services, Health, Insurance, Health Insurance, Managed Care, General Health, GAAP, ID, Telephone, PDF, Humana, News, Inc.

Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2024 (1Q24), as well as prepared management remarks (in PDF format), on Wednesday, April 24, 2024, at 6:30 a.m. Eastern time.

Key Points: 
  • Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2024 (1Q24), as well as prepared management remarks (in PDF format), on Wednesday, April 24, 2024, at 6:30 a.m. Eastern time.
  • The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024.
  • The company suggests participants for both the conference call and those listening via the web dial in or sign on at least 15 minutes in advance of the call.
  • The company’s 1Q24 earnings news release is expected to include financial measures that are not in accordance with Generally Accepted Accounting Principles (GAAP).

HealthTrackRx Appoints Leading Healthcare Expert Dr. Steven Goldberg as Chief Medical Officer

Retrieved on: 
Tuesday, April 9, 2024
Diagnosis, PCR, Medicine, Infection, Coventry Health Care, Thomas Jefferson University, Partnership, Georgetown University, Greater Louisville Inc., Humana, Standard of care, MD, MBA, Quality, WellCare, Express Scripts, Approximation error, Region, Kaiser Permanente, CMO, Binghamton University, Quest Diagnostics

DENTON, Texas, April 9, 2024 /PRNewswire/ -- HealthTrackRx, the nation's premier molecular diagnostic testing laboratory, today announced the appointment of Steven Goldberg, MD, MBA, as its Chief Medical Officer (CMO).

Key Points: 
  • DENTON, Texas, April 9, 2024 /PRNewswire/ -- HealthTrackRx, the nation's premier molecular diagnostic testing laboratory, today announced the appointment of Steven Goldberg, MD, MBA, as its Chief Medical Officer (CMO).
  • In the newly created role, Dr. Goldberg will lead the Company's partnership with payors, clinicians, and industry to enhance access to faster, better diagnostics.
  • A distinguished physician and respected healthcare innovator, Dr. Goldberg previously served as Chief Health Officer and Vice President of Medical Affairs at Quest Diagnostics and, preceding that, more than a decade in leading roles of several major health plans, including Chief Medical Officer at WellCare Health Plans, Senior Medical Director at Coventry Health Care, Chief of Medical Affairs at Express Scripts, Corporate Medical Director, Clinical Policy and Quality at Humana, Regional Chief Medical Officer at Excellus BCBS, Network Medical Director at Aetna Health Plans, and Medical Director at Kaiser Permanente NE.
  • "HealthTrackRx is transforming antibiotic stewardship protocols and helping payors and health plans manage spending by eliminating unnecessary tests, misdiagnosis, and ineffective antibiotic treatment.

Investor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the Firm

Retrieved on: 
Monday, March 25, 2024
CFO, Risk, District court, UnitedHealth Group, Defendant, Lead, LLP, COPY, News, PMPM, Humana, Medicare, Court

Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.

Key Points: 
  • Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

Humana Healthy Horizons – Ohio partners with CPESN® USA to expand access to pharmacists

Retrieved on: 
Tuesday, April 2, 2024
Seniors, Insurance, Pharmaceutical, General Health, Health, Professional Services, Health Insurance, Consumer, Community, Doctor of Pharmacy, Partnership, Pharmacy, Humana, Pharmacist, Transport, Doctor of Philosophy, MBA, Medicaid, Patient safety, Multimedia

Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana, announced it is partnering with CPESN® USA in Ohio to expand access to pharmacists for its members throughout the state.

Key Points: 
  • Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana, announced it is partnering with CPESN® USA in Ohio to expand access to pharmacists for its members throughout the state.
  • “Our partnership with CPESN USA will increase access to care for thousands of Ohioans,” said Kathie Mancini, President, Humana Healthy Horizons – Ohio.
  • By significantly expanding its pharmacist network through the selection of CPESN® Ohio pharmacies, Humana Healthy Horizons – Ohio is demonstrating its commitment to quality, accessible care.
  • Humana Healthy Horizons – Ohio serves more than 115,000 members across the state, with a keen focus on addressing the most pressing health-related social needs affecting the communities it serves.

Investor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the Firm

Retrieved on: 
Monday, March 25, 2024
Class Action Lawsuit, Professional Services, Legal, CFO, Risk, District court, UnitedHealth Group, Defendant, Lead, LLP, COPY, News, PMPM, Humana, Medicare, Court, Pharmaceutical industry

Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.

Key Points: 
  • Important Deadline Reminder: There is one related class action case pending against agilon in the United States District Court for the Western District of Texas.
  • The filing of the Hope Action does not change the May 20, 2024, lead plaintiff deadline.
  • Kessler Topaz Meltzer & Check, LLP encourages agilon investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

Petauri Welcomes Dan Vanderpoel

Retrieved on: 
Tuesday, April 2, 2024
Executive, Organization, Humana, Marketing, Head, Sales

NASHVILLE, Tenn., April 2, 2024 /PRNewswire/ -- Petauri, a leading purpose-built pharmaceutical services platform, announced today that Dan Vanderpoel has joined the company in the dual role of Executive Vice President, Strategic Payer Marketing, and Head, Client Solutions.

Key Points: 
  • NASHVILLE, Tenn., April 2, 2024 /PRNewswire/ -- Petauri, a leading purpose-built pharmaceutical services platform, announced today that Dan Vanderpoel has joined the company in the dual role of Executive Vice President, Strategic Payer Marketing, and Head, Client Solutions.
  • Dan will report to Petauri CEO, Dan Renick.
  • "The market access landscape continues to evolve, presenting opportunities and challenges for the biopharmaceutical industry as companies launch new products and technologies," said Dan Vanderpoel.
  • "Dan brings a wealth of experience and significant industry recognition to Petauri, particularly because of his extensive strategic contributions in market access and payer marketing," said Dan Renick.

Clarifai Named a Leader in Computer Vision Tools Report by Independent Research Firm

Retrieved on: 
Thursday, March 28, 2024
Organization, Senior, Lowe's, LLM, Architecture, Data management, NVIDIA, Private sector, Government, Humana, Clarifai, Medical device

WASHINGTON, March 28, 2024 /PRNewswire/ -- Clarifai , a global leader in AI development and a pioneer of the full-stack AI platform, was named a leader in The Forrester Wave™ : Computer Vision Tools, Q1 2024 .

Key Points: 
  • WASHINGTON, March 28, 2024 /PRNewswire/ -- Clarifai , a global leader in AI development and a pioneer of the full-stack AI platform, was named a leader in The Forrester Wave™ : Computer Vision Tools, Q1 2024 .
  • Clarifai is a full-stack AI, LLM, and computer vision (CV) production platform that simplifies how enterprise developers and teams create, share, and operationalize AI at scale.
  • Forrester notes that Clarifai aims to "reduce complexity with a best-of-breed full-stack infrastructure, foundational models, frameworks, model orchestration, fine-tuning, and supervision all under one umbrella."
  • Clarifai received the highest scores possible in 23 of 28 criteria, including data management, model development, model inferencing, architecture, vision, innovation, roadmap, and partner ecosystem.

Clarifai Named a Leader in Computer Vision Tools Report by Independent Research Firm

Retrieved on: 
Thursday, March 28, 2024
Organization, Senior, Lowe's, LLM, Architecture, Data management, NVIDIA, Private sector, Government, Humana, Clarifai, Medical device

WASHINGTON, March 28, 2024 /PRNewswire/ -- Clarifai , a global leader in AI development and a pioneer of the full-stack AI platform, was named a leader in The Forrester Wave™ : Computer Vision Tools, Q1 2024 .

Key Points: 
  • WASHINGTON, March 28, 2024 /PRNewswire/ -- Clarifai , a global leader in AI development and a pioneer of the full-stack AI platform, was named a leader in The Forrester Wave™ : Computer Vision Tools, Q1 2024 .
  • Clarifai is a full-stack AI, LLM, and computer vision (CV) production platform that simplifies how enterprise developers and teams create, share, and operationalize AI at scale.
  • Forrester notes that Clarifai aims to "reduce complexity with a best-of-breed full-stack infrastructure, foundational models, frameworks, model orchestration, fine-tuning, and supervision all under one umbrella."
  • Clarifai received the highest scores possible in 23 of 28 criteria, including data management, model development, model inferencing, architecture, vision, innovation, roadmap, and partner ecosystem.